cefuroxime has been researched along with Bacterial Infections, Gram-Positive in 16 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A randomized, double-blind, double-dummy, three-arm parallel design, multicentre study was conducted among adult patients with acute exacerbation of chronic bronchitis (AECB) in order to compare the efficacy and safety of two different doses of levofloxacin with cefuroxime axetil." | 9.09 | Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. ( Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R, 1999) |
| "A randomized, double-blind, double-dummy, three-arm parallel design, multicentre study was conducted among adult patients with acute exacerbation of chronic bronchitis (AECB) in order to compare the efficacy and safety of two different doses of levofloxacin with cefuroxime axetil." | 5.09 | Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study. ( Dolmann, A; Fiss, E; Maesen, FP; Shah, PM; Vetter, N; Wesch, R, 1999) |
| "Number of postoperative surgical site infections." | 2.72 | The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam. ( Dervisoglou, A; Galanakis, N; Giamarellou, H; Giannakakis, P; Iordanou, C; Kanellakopoulou, K; Karampali, E; Liveranou, S; Ntasiou, P; Pierakakis, S; Pinis, S; Tsiodras, S, 2006) |
| "Cefuroxime axetil is a broad spectrum antibacterial agent with a pharmacokinetic profile that permits convenient twice-daily administration." | 2.41 | Cefuroxime axetil: an updated review of its use in the management of bacterial infections. ( Goa, KL; Ormrod, D; Scott, LJ, 2001) |
| "Cefuroxime was the initial empiric antimicrobial agent given for 66/76 of the patients and treatment outcome was favorable for 20/22 patients who received cefuroxime at least up to day 5." | 1.72 | Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland. ( Grönroos, JO; Lehtola, L; Pakarinen, L; Pätäri-Sampo, A; Rantakokko-Jalava, K; Sihvonen, R; Turunen, M, 2022) |
| "Several studies on nuclear tissue from herniated discs have demonstrated the presence of low virulent anaerobic microorganisms, predominantly Propionibacterium acnes, in 7-53 % of patients." | 1.39 | Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae? ( Albert, HB; Busch, F; Elliott, T; Lambert, P; Manniche, C; Nørgaard, HS; Pedersen, MB; Rollason, J; Sorensen, JS; Vernallis, A; Worthington, T, 2013) |
| " Urine samples were taken every 2 h during the whole dosing interval of the particular antibiotic." | 1.33 | Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model. ( Bedenic, B; Bubonja, M; Budimir, A; Topic, M, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (25.00) | 18.2507 |
| 2000's | 6 (37.50) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Sihvonen, R | 1 |
| Turunen, M | 1 |
| Lehtola, L | 1 |
| Pakarinen, L | 1 |
| Grönroos, JO | 1 |
| Rantakokko-Jalava, K | 1 |
| Pätäri-Sampo, A | 1 |
| Chatterjee, S | 1 |
| Agrawal, D | 1 |
| Siesing, PC | 1 |
| Alva-Jørgensen, JP | 1 |
| Brodersen, J | 1 |
| Arpi, M | 1 |
| Jensen, PE | 1 |
| Guclu, E | 1 |
| Pandita, A | 1 |
| Murphy, C | 1 |
| Albert, HB | 1 |
| Lambert, P | 1 |
| Rollason, J | 1 |
| Sorensen, JS | 1 |
| Worthington, T | 1 |
| Pedersen, MB | 1 |
| Nørgaard, HS | 1 |
| Vernallis, A | 1 |
| Busch, F | 1 |
| Manniche, C | 1 |
| Elliott, T | 1 |
| Barnes, NP | 1 |
| Hull, J | 1 |
| Thomson, AH | 1 |
| Bedenic, B | 1 |
| Topic, M | 1 |
| Budimir, A | 1 |
| Bubonja, M | 1 |
| Dervisoglou, A | 1 |
| Tsiodras, S | 1 |
| Kanellakopoulou, K | 1 |
| Pinis, S | 1 |
| Galanakis, N | 1 |
| Pierakakis, S | 1 |
| Giannakakis, P | 1 |
| Liveranou, S | 1 |
| Ntasiou, P | 1 |
| Karampali, E | 1 |
| Iordanou, C | 1 |
| Giamarellou, H | 1 |
| Kailasanathan, A | 1 |
| Anderson, DF | 1 |
| Munir, WM | 1 |
| El Mallah, MK | 1 |
| Janda, WM | 1 |
| Tu, EY | 1 |
| Erjavec, Z | 1 |
| de Vries-Hospers, HG | 1 |
| van Kamp, H | 1 |
| van der Waaij, D | 1 |
| Halie, MR | 1 |
| Daenen, SM | 1 |
| Suvorova, MP | 1 |
| Iakovlev, SV | 1 |
| Shakhova, TV | 1 |
| Dvoretskiĭ, LI | 1 |
| Shah, PM | 1 |
| Maesen, FP | 1 |
| Dolmann, A | 1 |
| Vetter, N | 1 |
| Fiss, E | 1 |
| Wesch, R | 1 |
| Scott, LJ | 1 |
| Ormrod, D | 1 |
| Goa, KL | 1 |
| Chambers, ST | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Probiotics for Modic Changes: a Randomised Controlled Study to Elucidate the Effect of Probiotics on Vertebral Inflammatory End-plate Changes, So-called Type 1 Modic Changes[NCT03100266] | 94 participants (Actual) | Interventional | 2016-01-14 | Completed | |||
| Subclinical Propionibacterium Acnes Infection Estimation in the Intervertebral Disc (SPInE-ID): a Prospective Cohort[NCT03158766] | 108 participants (Actual) | Observational | 2017-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for cefuroxime and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
Topics: Age Factors; Cefuroxime; Cephalosporins; Clinical Trials as Topic; Economics, Pharmaceutical; Female | 2001 |
Which cephalosporin?
Topics: Bacterial Infections; Cefazolin; Cefoxitin; Cefuroxime; Cephalexin; Cephalosporins; Drug Costs; Gram | 1992 |
5 trials available for cefuroxime and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Medical management of parapneumonic pleural disease.
Topics: Adolescent; Anti-Bacterial Agents; Cefuroxime; Chest Tubes; Child; Child, Preschool; Double-Blind Me | 2005 |
The value of chemoprophylaxis against Enterococcus species in elective cholecystectomy: a randomized study of cefuroxime vs ampicillin-sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; Cefuroxime; Chemoprevention; Cholecystectomy; Elective Surgical P | 2006 |
Comparison of imipenem versus cefuroxime plus tobramycin as empirical therapy for febrile granulocytopenic patients and efficacy of vancomycin and aztreonam in case of failure.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Aztreonam; Cefuroxime; Drug Therapy, Combination; Female; | 1994 |
[Program of empirical antibacterial therapy of community-acquired pneumonia].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infect | 1998 |
Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chron | 1999 |
9 other studies available for cefuroxime and Bacterial Infections, Gram-Positive
| Article | Year |
|---|---|
Clinical and microbiological characterization of Aerococcus urinae bacteraemias at Helsinki metropolitan area, Finland.
Topics: Aerococcus; Aged; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Cefuroxime; Disease Susceptibility | 2022 |
5% cefuroxime as an alternative to 5% cefazolin in the treatment of Gram-positive bacterial keratitis.
Topics: Anti-Bacterial Agents; Cefazolin; Cefuroxime; Dose-Response Relationship, Drug; Eye Infections, Bact | 2018 |
Rising incidence of Enterococcus species in microbiological specimens from orthopedic patients correlates to increased use of cefuroxime: a study concentrating on tissue samples.
Topics: Anti-Bacterial Agents; Cefuroxime; Cross Infection; Denmark; Drug Utilization; Enterococcus; Gram-Po | 2013 |
Rising incidence of Enterococcus species in microbiological specimens from orthopedic patients correlates to increased use of cefuroxime.
Topics: Anti-Bacterial Agents; Cefuroxime; Enterococcus; Gram-Positive Bacterial Infections; Humans; Orthope | 2014 |
Microbial keratitis in Waikato, New Zealand.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefuroxime; Child; Child, Preschool; Corneal Ulcer; Eye | 2011 |
Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae?
Topics: Adult; Anti-Bacterial Agents; Bone Diseases; Cefuroxime; Cohort Studies; Edema; Female; Follow-Up St | 2013 |
Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae?
Topics: Adult; Anti-Bacterial Agents; Bone Diseases; Cefuroxime; Cohort Studies; Edema; Female; Follow-Up St | 2013 |
Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae?
Topics: Adult; Anti-Bacterial Agents; Bone Diseases; Cefuroxime; Cohort Studies; Edema; Female; Follow-Up St | 2013 |
Does nuclear tissue infected with bacteria following disc herniations lead to Modic changes in the adjacent vertebrae?
Topics: Adult; Anti-Bacterial Agents; Bone Diseases; Cefuroxime; Cohort Studies; Edema; Female; Follow-Up St | 2013 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; | 2006 |
Infectious crystalline keratopathy caused by Gemella haemolysans.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Corneal Diseases; Drug Therapy, Combinat | 2007 |
Gemella haemolysans infectious crystalline keratopathy.
Topics: Anti-Bacterial Agents; Cefuroxime; Colony Count, Microbial; Corneal Diseases; Drug Therapy, Combinat | 2008 |